Karuna Therapeutics
Stock Forecast, Prediction & Price Target
Karuna Therapeutics Financial Estimates
Karuna Therapeutics Revenue Estimates
Karuna Therapeutics EBITDA Estimates
Karuna Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $36.96M N/A | $10.63M -71.22% | $654K -93.85% | Avg: $256.78M Low: $103.73M High: $442.16M avg. 39163.16% | Avg: $690.34M Low: $280.42M High: $1.34B avg. 168.84% | Avg: $1.41B Low: $572.89M High: $2.75B avg. 104.29% | Avg: $2.45B Low: $995.63M High: $4.79B avg. 73.79% |
Net Income
% change YoY
| $-143.80M N/A | $-276.33M -92.16% | $-433.68M -56.93% | Avg: $-331.10M Low: $-486.75M High: $-79.83M avg. 23.65% | Avg: $37.76M Low: $-323.02M High: $528.14M avg. 111.40% | Avg: $469.67M Low: $107.12M High: $1.05B avg. 1143.72% | Avg: $1.05B Low: $240.59M High: $2.36B avg. 124.59% |
EBITDA
% change YoY
| $-143.15M N/A | $-289.67M -102.35% | $-493.07M -70.21% | Avg: $-51.35M Low: $-88.43M High: $-20.74M avg. 89.58% | Avg: $-138.06M Low: $-269.88M High: $-56.08M avg. -168.84% | Avg: $-282.06M Low: $-551.35M High: $-114.57M avg. -104.29% | Avg: $-490.19M Low: $-958.19M High: $-199.12M avg. -73.79% |
EPS
% change YoY
| -$4.94 N/A | -$8.74 -76.92% | -$11.73 -34.21% | Avg: -$8.23 Low: -$13.17 High: -$2.16 avg. 29.84% | Avg: $0.66 Low: -$8.74 High: $14.29 avg. 108.00% | Avg: $12.71 Low: $2.9 High: $28.48 avg. 1829.19% | Avg: $28.54 Low: $6.51 High: $63.97 avg. 124.59% |
Operating Expenses
% change YoY
| $180.81M N/A | $300.31M 66.08% | $495.43M 64.97% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Karuna Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 350.84% in 2025-2028.
We have gathered data from 9 analysts. Their low estimate is -486.75M, average is -331.10M and high is -79.83M.
What is Karuna Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 9877.52% in 2025-2028.
We have gathered data from 10 analysts. Their low revenue estimate is $103.73M, average is $256.78M and high is $442.16M.
What is Karuna Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 522.91% in 2025-2028.
We have gathered data from 9 analysts. Their low earnings per share estimate is -$13.17, average is -$8.23 and high is $-2.16.
What is the best performing analyst?
In the last twelve months analysts have been covering Karuna Therapeutics stock. The most successful analyst is Raghuram Selvaraju.